Accelerating Medicines Partnership® SCHIZOPHRENIA
News and Updates
Keep up with the latest news about the Accelerating Medicines Partnership (AMP®) SCZ program.

AMP SCZ Papers in Progress

Below is a list of AMP SCZ publications currently in progress. To view published AMP SCZ papers, please visit PubMed.

  1. “Clinical Subtype Detection in the CHR Population.” John Torous, Andrew (Jin Soo) Byun, et al.
  2. “Machine Learning and Digital Phenotyping to Predict Suicidality in a Clinical High Risk Sample: Baseline Data from AMP SCZ.” Alex Dhima, Erlend Lane, John Torous, et al.
  3. “Characterizing grey- and white-matter heterogeneity and stability in CHR individuals using normative modeling.” Cassandra Wannan, Dominic Dwyer, Barnaby Nelson, Stephen Wood, Sandra Vieira, Kelly Allott, William Stone, et al.
  4. “Prevalence of general medical conditions in individuals at clinical high risk for psychosis and its association with symptoms and functioning.” Beier Yao, Eve Lewandowski, John Torous, et al.
  5. “Digital phenotyping of sleep in the CHR population.” John Torous, Andrew (Jin Soo) Byun, et al.
  6. “Objective Sleep Midpoint Estimation from Phone Sensor Data: A predictor of Depressive Episodes.” Habib Rahimi Eichi, Yoon Chung, Justin Baker, et al.
  7. “Predicting Elevated Negative Affective States from Smartphone Sensors in Clinical High-Risk Individuals: Personalized Machine Learning Approach.” Yoonhoo Chung, Habib Rahimi Eichi, Justin Baker, et al.
  8. “Actigraphy-based Individualized Energy Imbalance Association with Negative Affect.” Habib Rahimi Eichi, Yoon Chung, Justin Baker, et al.
  9. “Prediction of Affective and Psychotic Symptoms Using Smartphone-Based EMA Survey and Phone Sensor in Individuals at Clinical High-Risk.” Yoonhoo Chung, Habib Rahimi Eichi, Justin Baker, et al.
  10. “Investigating Missingness Patterns in EMA and Passive Sensor Data.” Yoonhoo Chung, Habib Rahimi Eichi, Justin Baker, John Torous, Ofer Pasternak, et al.
  11. “Identifying the structural and effective connectivity measures differentiating people at clinical high risk for psychosis from healthy controls.” Elise Rowe, Barnaby Nelson, Stephen Wood, Suzie Lavoie, Thomas Whitford, Dan Mathalon, et al.
  12. “Protocol for Improving Smartphone Data Quality in a Longitudinal, International Multisite Study: Efforts from AMP SCZ.” Erlend Lane, Jane Mikkelson, Matt Flathers, John Torous, et al.
  13. “Modification of the Family Interview for Genetic Studies (FIGS) for AMP® Schizophrenia.” Sinead Kelly, Diana Perkins, et al.
  14. “Interim Characterization of Multimodal Outcome Measures from The Accelerating Medicines Partnership Schizophrenia Baseline Data.” Johanna Seitz-Holland, Nora Penzel, Ofer Pasternak, et al.
  15. “Combining Large Language Models and Feedback From Clinical High Risk Individuals To Identify Features of Lived Experience Narratives.” Jenna Reinen, et al.
  16. “Automatic Assessment of the Scale of Prodromal Symptoms (SOPS) Using Large Language Models.” Carla Agurto, et al.
  17. “Understanding Cognitive Heterogeneity and its Link with Neural Activity Patterns in Clinical High-Risk Patients: Implications for Treatment.” Michael Sand, et al.
  18. “Incidence, Prevalence, and Stability of Remission over Time in Individuals at CHR for Psychosis.” Ofer Pasternak, Marty Shenton, et al.
  19. “Replicating and extending relationships between premorbid adjustment, symptoms, and cognition in clinical high risk for psychosis.” Henery R. Cowan, Vijay A. Mittal, et al.
  20. “Uncovering Cognitive and Neuroanatomical Differences: Investigation of the Impact of Childhood Trauma on Healthy and At-risk for Psychosis Individuals in the Context of Adverse Life Events.” Oznur Basturk, Lana Kambeitz-Ilankovic, et al.
  21. “Elucidating the Association between Cognitive and Social Functioning Using Digital Markers in Individuals at CHR-P.” Julian Wenzel, Lana Kambeitz-Ilankovic, Joseph Kambeitz, et al.
  22. “Baseline Severity of General Psychopathology in Youth at Clinical High-Risk for Psychosis Worldwide: Cross-Cultural Evidence from the Accelerating Medicines Partnership (AMP) Schizophrenia (SCZ) Program and Comparison with Previous Cohorts.” Gabriele Lo Buglio, et al.
  23. “The Effects of Childhood Trauma and Adversity on Social Cognition and Functioning in Individuals at a Clinical High Risk of Psychosis.” Julia Szacilo, et al.
  24. “Concordance of SIPS and CAARMS Criteria for Clinical High Risk and Symptom Significance Classification in the Positive Symptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS (PSYCHS).” Alyssa Bathery, et al.
  25. “The association between sleep quality and quantity and clinical high-risk status.” Johanna Seitz-Holland, et al.
  26. “The impact of cannabis legalization on the association between cannabis use and attenuated psychotic symptoms – results from the worldwide AMP SCZ study.” Nora Penzel, Sinead M. Kelly, et al.
  27. “Preliminary Psychometric Properties of the 15 items of the Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.” Catalina Mourgues, et al.
  28. “A shift to female preponderance in a recent sample of individuals at a clinical high risk for psychosis (CHR-P).” Emily Farina, et al.
  29. “Examining the impact of neighborhood factors and experienced discrimination on psychosis symptoms and functioning among marginalized young adults.” Jason Schiffman, et al.
  30. “Neural Signatures of Hallucination Emergence in a Clinical High-Risk Population.” Al Powers, et al.
  31. “Examining a Hierarchical Taxonomy of Symptoms for Individuals at CHR.” Trevor Williams, et al.
  32. “Longitudinal Psychometric Validation of the Negative Symptom Inventory- Psychosis Risk (NSI-PR) in AMP SCZ.” Gregory Strauss, Vijay Mittal, et al.
  33. “Exploring the clinical and functional correlates of childhood trauma in Clinical High Risk for psychosis patients.” Luis Alameda, et al.
  34. “Predictive Modelling of Future Suicidal Ideation and Attempts in Clinical High Risk Population using Machine Learning.” Josh Nguyen, et al.
  35. “Social and Role Functioning in the AMP SCZ Study: Description and correlates.” Ricardo E Carrion, Barbara Cornblatt, et al.
  36. “Assessment of the stability and repeatability of speech features and their relationship with clinical measures.” Simon Hartmann, Isabelle Scott, et al.
  37. “Suicide Risk in CHR: Relationship with Symptoms, Stress and Sleep.” Heather Wastler, Nicholas Breitborde, Aubrey Moe, Lexi Blouin, et al.
  38. “The Effect of Cognition on Real-World Functioning for Individuals at Clinical High-Risk for Psychosis.” Danielle N. Pratt, Vijay Mittal, et al.
  39. “Incorporating lived experience in AMP SCZ: The WOW factor or Bridging Science and Hope: Integrating and Communicating Lived Experience in AMP SCZ.” Tina Kapur, Eve Lewandowski, Carlos Larrauri, et al.
  40. “The AMP SCZ analysis plan: Machine learning approaches for the prediction of clinical endpoints in individuals at clinical high-risk to develop psychosis.” Ofer Pasternak, Guillermo Cecchi, Linda Brady, et al.
  41. “Data Operations for the AMPSCZ Project. Enabling FAIR data stewardship in complex international multi-site studies.” Justin Baker, Sylvain Bouix, et al.
  42. “Strategies for Collecting Language Samples to Forecast the Onset of Psychosis in Clinical High-Risk Individuals.” Zarina R. Bilgrami, Michaela Ennis, Einat Liebenthal, Eduardo Castro, Carla Agurto, Justin T. Baker, Barnaby Nelson, Guillermo A. Cecchi, Cheryl M. Corcoran, Phillip Wolff, et al.
  43. “Body fluid biomarkers and psychosis risk in AMP-SCZ: Design considerations.” Diana Perkins and Scott Clark, et al.
  44. “Electroencephalography-based event-related potential and event-related oscillation assessments in the AMP SCZ Study.” Daniel Mathalon, et al.
  45. “AMP SCZ MRI Protocol.” Ofer Pasternak, Michael Harms, Carrie E Bearden, Stephen Wood, et al.
  46. “Cognitive assessment in the AMP-SCZ initiative: Harmonization priorities and strategies in a diverse international sample.” Kelly Allott and Bill Stone, et al.
  47. “Digital Team Protocol Paper: Title TBD.” John Torous, et al.
  48. “CHR-P Status, Symptoms, and Correlates among Gender Expansive Youth.” Laura Adery, Vanessa Calderon, Dylan Hughes, Daisy Lopez, Carrie Bearden, et al.

Last Reviewed on November 22, 2024